Terms ending in 2033
Every in-force patent on Hoffmann-La Roche Inc.'s record whose computed term ends in 2033, whoever holds it now. Soonest term end first, then patent number.
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,883,975 | Antibodies against IL-18R1 and uses thereof Grace period ended Nov 11, 2026 · lapse expected · Low confidence | Hoffmann-La Roche Inc. | Grace period ended Nov 11, 2026 lapse expected | Low confidence | |
| US 10,684,227 | Method for Detection of Binding Affinities In force · Medium confidence | Hoffmann-La Roche Inc. | In force | Medium confidence | |
| US 9,067,926 | FLUOROMETHYL-5,6-Dihydro-4H-[1,3]OXAZINES In force · High confidence | Siena Biotech S.P.A. and Hoffmann-La Roche Inc. | In force | High confidence | |
| US 11,491,178 | Chitosan Covalently Linked with Small Molecule Integrin Antagonist for Targeted Delivery In force · Medium confidence | Hoffmann-La Roche, Inc. | In force | Medium confidence | |
| US 9,346,824 | CYCLOHEXYL-4H,6H-5-OXA-2,3,10B-TRIAZA-BENZO[E]AZULENES as V1A Antagonists In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,636,680 | Sample Handling System In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,353,081 | New Bicyclic DIHYDROQUINOLINE-2-ONE Derivatives In force · High confidence | Cincor Pharma, Inc. | In force | High confidence | |
| US 9,216,170 | Combination Therapy for Proliferative Disorders In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,486,445 | Combination Therapy for Proliferative Disorders In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| US 9,879,007 | Compounds for Treating Spinal Muscular Atrophy In force · High confidence | Hoffmann-La Roche Inc. | In force | High confidence | |
| 54 more term ends in 2033 · Pro | |||||
10 of 64 patents shown. Soonest term end first, then patent number.
Pro members see all 64.
52 of these are in force and held by Hoffmann-La Roche Inc..
Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.